Skip to main content
SpringerLink
Log in

Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: differentiation from progressive supranuclear palsy

  • Regular Paper
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract

Corticobasal degeneration (CBD) is a rare, progressive neurological disorder characterized by widespread neuronal and glial accumulation of abnormal tau protein. Using immunohistochemistry we analyzed tau epitope expression and phosphorylation state in CBD and compared them to cytoskeletal changes in Alzheimer's disease (AD) and progressive supranuclear palsy (PSP). Epitopes spanning the entire length of the tau protein were present in CBD inclusions. An antibody against the alternatively spliced exon 3 did not recognize cytoskeletal lesions in CBD, but did in AD and PSP. Tau epitopes from each region of the molecule were present in cytoskeletal inclusions in CBD, including gray matter astrocytic plaques, gray and white matter threads, and oligodendroglial inclusions. As in AD, tau from CBD was highly phosphorylated. Antibodies that recognized phosphorylated tau epitopes reacted with material from CBD in a highly phosphatase-dependent manner. Again, all types of inclusions contained phosphorylated epitopes. We conclude that abnormal tau protein in CBD comprises the entire tau molecule and is highly phosphorylated, but is distinguished from AD and PSP by the paucity of epitopes contained in the alternatively spliced exon 3.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bancher C, Lassmann H, Budka H, Grundke-Iqbal I, Iqbak K, Wiche G, Seitelberger F, Wisniewski HM (1987) Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences. Acta Neuropathol (Berl) 74: 39–46

    Google Scholar 

  2. Biernat J, Mandelkow EM, Schroter C, Lichtenberg-Kragg B, Steiner B, Berling B, Meyer H, Mercken M, Vandermeeren A, Goedert M, Mandelkow E (1992) The switch of tau protein to an Alzhemier-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J 11: 1593–1597

    Google Scholar 

  3. Binder LI, Frankfurter A, Rebhun L (1985) The distribution of tau polypeptides in the mammalian central nervous system. J Cell Biol 101: 1371–1378

    Google Scholar 

  4. Cruz-Sanchez FF, Rossi ML, Cardozo A, Deacon P, Tolosa E (1992) Clinical and pathological study of two patients with progressive supranuclear palsy and Alzheimer's changes. Antigenic determinants that distinguish cortical and subcortical neurofibrillary tangles. Neurosci Lett 136: 43–46

    Google Scholar 

  5. Davies P, Ghanbari H, Issacs A, Dickson DW, Mattiace LA, Rosado M, Vincent IJ (1993) TG3: a better antibody than Alz-50 for the visualization of Alzheimer-type neuronal pathology (abstract). Soc Neurosci 1636

  6. Dickson DW, Mattiace LA (1992) Immunocytochemical studies distinguish corticobasal degeneration from progressive supranuclear palsy (abstract). J Neuropathol Exp Neurol 51: 321

    Google Scholar 

  7. Dickson DW, Yen S-H, Horoupian DS (1986) Pick body-like inclusions in the dentate fascia of the hippocampus in Alzheimer's disease. Acta Neuropathol (Berl) 71: 38–45

    Google Scholar 

  8. Dickson DW, Ksiezak-Reding H, Liu WK, Davies P, Crowe A, Yen S-H (1992) Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site. Acta Neuropathol 84: 596–605

    Google Scholar 

  9. Dickson DW, Liu W-K, Kress Y, Ku J, DeJesus O, Yen S-HC (1993) Phosphorylated tau immunoreactivity of granulovacuolar bodies (GVB) of Alzheimer's disease: localization of two amino-terminal tau epitopes in GVB. Acta Neuropathol 85: 463–470

    Google Scholar 

  10. Drubin DG, Kirschner MW (1986) Tau protein function in living cells. J Cell Biol 103: 2739–2746

    Google Scholar 

  11. Feany MB, Dickson DW (1995) Widespread cytoskeletal pathology characterize corticobasal degeneration. Am J Pathol 147 (in press)

  12. Flament S, Delacourte A, Vernu M, Hauw J-J, Javoy-Agid F (1991) Abnormal tau proteins in progressive supranuclear palsy. Acta Neuropathol 81: 591–596

    Google Scholar 

  13. Gibb WRG, Luthert PJ, Marsden CD (1989) Corticobasal degeneration. Brain 112: 1171–1192

    Google Scholar 

  14. Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3: 519–526

    Google Scholar 

  15. Goedert M, Spillantini MG, Cairns NY, Crowther RA (1992) Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8:159–168

    Google Scholar 

  16. Greenberg SG, Davies P (1990) A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci USA 87: 5827–5831

    Google Scholar 

  17. Iwatsubo T, Hasegawa M, Ihara Y (1994) Neuronal and glial tau-positive inclusions in diverse neurologic disease share common phosphorylation characteristics. Acta Neuropathol 88: 129–136

    Google Scholar 

  18. Khachaturian ZS (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42: 1097–1105

    Google Scholar 

  19. Kosik K, Joachim CL, Selkoe DJ (1986) Microtubule-associated protein tau (τ) is a major antigenic component of paired helical filaments in Alzheimer's disease. Proc Natl Acad Sci USA 83: 4044–4048

    Google Scholar 

  20. Kosik D, Orecchio KD, Binder LI, Trojanowski JQ, Lee VMY, Lee G (1988) Epitopes that span the tau molecule are shared with paired helical filaments. Neuron 1: 817–825

    Google Scholar 

  21. Ksiezak-Reding H, Morgan K, Mattiace LA, Davies P, Liu W-K, Yen S-H, Weidenheim K, Dickson DW (1994) Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. Am J Pathol 145: 1–13

    Google Scholar 

  22. Lang AE, Riley DE, Bergeron C (1994) Cortico-basal ganglionic degeneration. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 877–894

    Google Scholar 

  23. Lerner A, Friedlan R, Riley D, Whitehouse P, Lanska D, Vick N, Cochran E, Tresser N, Cohen M, Gambetti P (1992) Dementia with pathological findings of cortical-basal degeneration (abstract). Ann Neurol 32: 271

    Google Scholar 

  24. Lippa CF, Smith TW, Fontneau N (1990) Corticonigral degeneration with neuronal achromasia. A clinicopathological study of two cases. J Neurol Sci 98: 301–310

    Google Scholar 

  25. Liu W-K, Ksiezak-Reding H, Yen S-H (1991) Abnormal tau proteins from Alzheimer's disease brains: purification and amino acid analysis. J Biol Chem 266: 21723–21727

    Google Scholar 

  26. Liu W-K, Dickson DW, Yen S-H (1993) Heterogeneity of tau protein in Alzheimer's disease. Am J Pathol 142: 387–394

    Google Scholar 

  27. Liu W-K, Dickson DW, Yen S-HC (1994) Amino acid residues 226–240 of τ, which encompass the first Lys-Ser-Pro site of τ, are partially phosphorylated in Alzheimer paired helical filament-τ. J Neurochem 62: 1055–1061

    Google Scholar 

  28. Matsuo ES, Shin R-W, Billingsley ML, Van de Voorde A, O'Connor M, Trojanowski JQ, Lee V M-Y (1994) Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 13: 989–1002

    Google Scholar 

  29. Mattiace LA, Wu E, Aronson M, Dickson DW (1991) A new neuritic plaque without amyloid in corticonigral degeneration with neuronal achromasia (abstract). J Neuropathol Exp Neurol 50:310

    Google Scholar 

  30. Mori H, Nishimura M, Namba Y, Oda M (1994) Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy. Acta Neuropathol 88: 113–121

    Google Scholar 

  31. Paulus W, Selim M (1990) Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles. Acta Neuropathol 81: 89–94

    Google Scholar 

  32. Probst A, Kangui D, Lautenschlager C, Ulrich J, Brion JP, Anderton BH (1988) Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles. Acta Neuropathol 77: 61–68

    Google Scholar 

  33. Rebeiz JJ, Kolodny EH, Richardson EP (1967) Corticodentatonigral degeneration with neuronal achromasia: a progressive disorder of late adult life. Trans Am Neurol Assoc 92: 23–26

    Google Scholar 

  34. Rebeiz JJ, Kolodny EH, Richardson EP (1968) Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 18: 20–33

    Google Scholar 

  35. Roy S, Datta CK, Hirano A, Ghatak NR, Zimmerman HM (1974) Electron microscopic study of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. Acta Neuropathol (Berl) 29: 175–179

    Google Scholar 

  36. Schmidt ML, Lee VM-Y, Hurtig H, Trojanowski JQ (1988) Properties of antigenic determinants that distinguish neurofibrillary tangles in progressive supranuclear palsy and Alzheimer's disease. Lab Invest 59: 460–466

    Google Scholar 

  37. Tellez-Nagel I, Wisiewski HM (1973) Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. Arch Neurol 29: 324–327

    Google Scholar 

  38. Wakabayashi K, Oyanagi K, Makifuchi T, Ikuta F, Honna A, Honna Y, Horikawa Y, Tokiguchi S (1994) Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations. Acta Neuropathol 87: 545–553

    Google Scholar 

  39. Wolozin GL, Pruchnicki A, Dickson DW, Davies P (1986) A neuronal antigen in the brain of Alzheimer patients. Science 232: 648–650

    Google Scholar 

  40. Yen S-H, Crowe A, Dickson DW (1985) Monoclonal antibodies to Alzheimer neurofibrillary tangles. I. Identification of polypeptides. Am J Pathol 120: 282–291

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology (Neuropathology), Kennedy Center for Research in Mental Retardation, Albert Einstein College of Medicine, 1300 Morris Park Ave., 10461, Bronx, NY, USA

    M. B. Feany, H. Ksiezak-Reding, W. -K. Liu, I. Vincent, S. -H. C. Yen & D. W. Dickson

Authors
  1. M. B. Feany
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Ksiezak-Reding
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. -K. Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. Vincent
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. -H. C. Yen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. W. Dickson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feany, M.B., Ksiezak-Reding, H., Liu, W.K. et al. Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: differentiation from progressive supranuclear palsy. Acta Neuropathol 90, 37–43 (1995). https://doi.org/10.1007/BF00294457

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00294457

Key words

Search

Navigation